O. Yu. Sokolov

483 total citations
35 papers, 359 citations indexed

About

O. Yu. Sokolov is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biological Psychiatry. According to data from OpenAlex, O. Yu. Sokolov has authored 35 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 8 papers in Biological Psychiatry. Recurrent topics in O. Yu. Sokolov's work include Neuropeptides and Animal Physiology (11 papers), Tryptophan and brain disorders (8 papers) and Receptor Mechanisms and Signaling (7 papers). O. Yu. Sokolov is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Tryptophan and brain disorders (8 papers) and Receptor Mechanisms and Signaling (7 papers). O. Yu. Sokolov collaborates with scholars based in Russia, United Kingdom and Tajikistan. O. Yu. Sokolov's co-authors include Н. В. Кост, A. A. Zozulya, Yu. A. Zolotarev, A. K. Dadayan, S. A. Grachev, Oleg Varlamov, N. F. Myasoedov, И. А. Гривенников, Л. А. Андреева and Smulevich Ab and has published in prestigious journals such as Experimental Gerontology, Peptides and Journal of Psychopharmacology.

In The Last Decade

O. Yu. Sokolov

31 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Yu. Sokolov Russia 10 165 79 63 56 53 35 359
A. A. Zozulya Russia 9 163 1.0× 100 1.3× 61 1.0× 51 0.9× 40 0.8× 26 351
Н. В. Кост Russia 11 250 1.5× 130 1.6× 94 1.5× 95 1.7× 59 1.1× 49 540
Waldemar Grzegorzewski Poland 14 68 0.4× 45 0.6× 37 0.6× 80 1.4× 55 1.0× 43 511
Xiaoyu Sun China 14 243 1.5× 90 1.1× 11 0.2× 50 0.9× 95 1.8× 38 555
Suzanne Hosie Australia 10 188 1.1× 53 0.7× 50 0.8× 78 1.4× 45 0.8× 13 447
Heidi Faber‐Zuschratter Germany 11 106 0.6× 125 1.6× 18 0.3× 24 0.4× 55 1.0× 13 539
Peter Ergang Czechia 15 217 1.3× 36 0.5× 17 0.3× 37 0.7× 163 3.1× 37 623
Tahereh Bozorgmehr Canada 10 144 0.9× 86 1.1× 47 0.7× 43 0.8× 112 2.1× 18 402
Kristina Malinovskaja Estonia 6 213 1.3× 56 0.7× 6 0.1× 72 1.3× 15 0.3× 6 345
Dennis Roggenkamp Germany 11 117 0.7× 109 1.4× 34 0.5× 12 0.2× 131 2.5× 13 575

Countries citing papers authored by O. Yu. Sokolov

Since Specialization
Citations

This map shows the geographic impact of O. Yu. Sokolov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Yu. Sokolov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Yu. Sokolov more than expected).

Fields of papers citing papers by O. Yu. Sokolov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Yu. Sokolov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Yu. Sokolov. The network helps show where O. Yu. Sokolov may publish in the future.

Co-authorship network of co-authors of O. Yu. Sokolov

This figure shows the co-authorship network connecting the top 25 collaborators of O. Yu. Sokolov. A scholar is included among the top collaborators of O. Yu. Sokolov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Yu. Sokolov. O. Yu. Sokolov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zozulya, Sergey, O. Yu. Sokolov, & Н. В. Кост. (2024). Effect of Neurotropic and Immunotropic Drugs on Leukocyte Elastase Activity In Vitro. Bulletin of Experimental Biology and Medicine. 176(5). 585–590. 1 indexed citations
2.
Zolotarev, Yu. A., О. В. Долотов, Dmitrii D. Markov, et al.. (2024). NEUROPROTECTIVE EFFECT OF HLDF-6-H PEPTIDE IN PARKINSON'S DISEASE.. 32–41.
3.
Zolotarev, Yu. A., С. И. Шрам, О. В. Долотов, et al.. (2022). HLDF-6 peptides exhibit neuroprotective effects in the experimental model of preclinical Parkinson's disease. Neuropeptides. 96. 102287–102287. 2 indexed citations
4.
Sokolov, O. Yu., et al.. (2021). Assessment of the Cytotoxicity of Peptide Modifications of Doxorubicin on Tetrahymena pyriformis. Doklady Biochemistry and Biophysics. 497(1). 104–107.
5.
Sokolov, O. Yu., T. A. Prokhorova, Е. Б. Терешкина, et al.. (2021). Neurotropic peptide HLDF-6-amide reduces age-related decline in sexual activity in old male rats. Experimental Gerontology. 149. 111329–111329. 4 indexed citations
6.
Лебедева, И. С., O. Yu. Sokolov, Alena Rumshiskaya, et al.. (2020). Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady Biological Sciences. 490(1). 9–11. 2 indexed citations
7.
Sokolov, O. Yu., et al.. (2019). Haloperidol Reduces the Activity of Complement and Induces the Anti-Inflammatory Transformation of Peritoneal Macrophages in Rats. Journal of Neuroimmune Pharmacology. 14(3). 369–374. 8 indexed citations
8.
Zolotarev, Yu. A., A. K. Dadayan, Н. В. Кост, et al.. (2015). The qualitative analysis of the amide of the HLDF-6 peptide and its metabolites in tissues of laboratory animals with the use of tritium-labeled and deuterium-labeled derivatives. Russian Journal of Bioorganic Chemistry. 41(6). 578–589. 8 indexed citations
9.
Sokolov, O. Yu., et al.. (2015). Dipeptidylpeptidase 4 (DPP4, CD26) activity in the blood serum of term and preterm neonates with cerebral ischemia. Neuropeptides. 52. 113–117. 8 indexed citations
10.
Sokolov, O. Yu., Н. В. Кост, A. K. Dadayan, et al.. (2014). Autistic children display elevated urine levels of bovine casomorphin-7 immunoreactivity. Peptides. 56. 68–71. 73 indexed citations
11.
Кост, Н. В., et al.. (2014). Neurotensin-Like Peptides as Potential Antipsychotics: Modulation of the Serotonin System. Bulletin of Experimental Biology and Medicine. 157(6). 738–741. 7 indexed citations
12.
Кост, Н. В., et al.. (2013). The influence of oligopeptides on spontaneous carcinogenesis in mice. Doklady Biological Sciences. 449(1). 79–81. 1 indexed citations
13.
Sokolov, O. Yu., et al.. (2009). [Naloxone-induced suppression of the behavioral manifestation of serotoninergic system hyperactivation by beta-casomorphins-7 in mice].. PubMed. 72(2). 3–5. 1 indexed citations
14.
Кост, Н. В., et al.. (2009). β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides. 30(10). 1854–1860. 76 indexed citations
15.
Кост, Н. В., et al.. (2008). [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].. PubMed. 108(4). 38–48. 9 indexed citations
16.
Sokolov, O. Yu., et al.. (2005). Reactions between β-Casomorphins-7 and 5-HT2-Serotonin Receptors. Bulletin of Experimental Biology and Medicine. 140(5). 582–584. 14 indexed citations
17.
Sokolov, O. Yu., et al.. (2005). Influence of Human B-Casomorphin-7 on Specific Binding of 3H-Spiperone to the 5-HT2-Receptors of Rat Brain Frontal Cortex. Protein and Peptide Letters. 13(2). 169–170. 6 indexed citations
18.
Sokolov, O. Yu., et al.. (2004). Half-Life of Leu-Enkephalin in the Serum of Infants of the First Year of Life on Different Types of Feeding: Relationship with Temperament. Bulletin of Experimental Biology and Medicine. 137(4). 342–344. 7 indexed citations
19.
Кост, Н. В., et al.. (2001). Semax and Selank Inhibit the Enkephalin-Degrading Enzymes of Human Serum. Russian Journal of Bioorganic Chemistry. 27(3). 156–159. 11 indexed citations
20.
Sokolov, O. Yu., et al.. (2001). Relationship between IFN-γ Production by Blood Lymphocytes and Constitutional Personality Features of Patients with Idiopathic Mitral Valve Prolapse. Bulletin of Experimental Biology and Medicine. 131(4). 389–391. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. A. Zozulya Breakdown of academic impact, for papers by Н. В. Кост Breakdown of academic impact, for papers by Waldemar Grzegorzewski Breakdown of academic impact, for papers by Xiaoyu Sun Breakdown of academic impact, for papers by Suzanne Hosie Breakdown of academic impact, for papers by Heidi Faber‐Zuschratter Breakdown of academic impact, for papers by Peter Ergang Breakdown of academic impact, for papers by Tahereh Bozorgmehr Breakdown of academic impact, for papers by Kristina Malinovskaja Breakdown of academic impact, for papers by Dennis Roggenkamp
Rankless by CCL
2026